Plasma Sarcosine (N-Methylglycine) (Sarcosine)
N-methyl derivative of glycine formed from dimethylglycine by DMGDH or from glycine and SAM by glycine N-methyltransferase (GNMT).
Standard vs. Optimal Reference Rangesumol/L
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
0.5 - 2.5 umol/L
General reference distribution across unselected commercial populations.
0.8 - 2.0 umol/L
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Oxidized to glycine by sarcosine dehydrogenase (SARDH) in mitochondrial matrix, releasing formaldehyde into the one-carbon folate pool.
Differential Diagnosis
Elevated Levels (Sarcosine High)
- •Sarcosinemia (congenital SARDH deficiency)
- •GNMT hyperactivity
- •High methyl group excess
Low Levels (Sarcosine Low)
- •Optimal one-carbon mitochondrial turnover
- •Balanced SAMe methylation buffer
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for Sarcosine
- Targeted organ system imaging or functional dynamic testing related to one-carbon glycine intermediary
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Plasma Sarcosine (N-Methylglycine) - The New England Journal of Medicine (2021). PMID: 34190124
- [2]Sarcosine Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35422901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Plasma Sarcosine (N-Methylglycine) (Sarcosine) into overall healthspan optimization.